Abstract
The Coronavirus disease 2019 (COVID-19) pandemic revealed our need for reliable tools to evaluate patients with skin disease virtually. Thus far, there has not been a study that has attempted to score the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), a validated outcome measure of skin activity and damage, from photographs. In this study, patients were prospectively recruited during routine clinic visits and skin regions used in scoring the CDASI were photographed by research staff using two iPhone cameras (an iPhone 8 and iPhone 11).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
